Pharmacotherapy for Status Epilepticus

@inproceedings{Trinka2015PharmacotherapyFS,
  title={Pharmacotherapy for Status Epilepticus},
  author={Eugen Trinka and Julia H{\"o}fler and Markus Leitinger and Francesco Brigo},
  booktitle={Drugs},
  year={2015}
}
Status epilepticus (SE) represents the most severe form of epilepsy. It is one of the most common neurologic emergencies, with an incidence of up to 61 per 100,000 per year and an estimated mortality of 20 %. Clinically, tonic-clonic convulsive SE is divided into four subsequent stages: early, established, refractory, and super-refractory. Pharmacotherapy of status epilepticus, especially of its later stages, represents an “evidence-free zone,” due to a lack of high-quality, controlled trials… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 6 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Treatment of Established Status Epilepticus.

Journal of clinical medicine • 2016
View 4 Excerpts
Highly Influenced

Levetiracetam in toxic seizures.

Clinical toxicology • 2018
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 219 references

Intramuscular versus intravenous therapy for prehospital status epilepticus.

The New England journal of medicine • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…